Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Risk Factors and Outcomes According to Age at Transplant with an HLA Identical Sibling for Sickle Cell Disease

Blood (2017) 130 (Supplement 1): 3317.

https://doi.org/10.1182/blood.V130.Suppl_1.3317.3317

Published: 2017

Journal Articles

Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation

Blood (2017) 129 (11): 1548–1556.

https://doi.org/10.1182/blood-2016-10-745711

Published: 2017

Journal Articles

Prophylactic CNS Therapy (with or without Radiation Therapy) in Medium-High Risk Acute Lymphoblastic Leukemia (ALL) Children: Long-Term Outcome Evaluation of the Randomized BFM-Oriented Trial 58832 (period 1983-1989) of the EORTC Children Leukemia Group

Blood (2016) 128 (22): 2775.

https://doi.org/10.1182/blood.V128.22.2775.2775

Published: 2016

Journal Articles

Metabolic Syndrome in Long-Term Survivors of Childhood Acute Leukemia Treated without Hematopoietic Stem Cell Transplantation: An L.E.Α. Study

Blood (2016) 128 (22): 695.

https://doi.org/10.1182/blood.V128.22.695.695

Published: 2016

Journal Articles

Late Effects in Survivors of Infantile Acute Leukemia Are Less Severe Than Expected: A Study of the L.E.a Program

Blood (2016) 128 (22): 3571.

https://doi.org/10.1182/blood.V128.22.3571.3571

Published: 2016

Journal Articles

Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome

Blood (2016) 127 (26): 3450–3457.

https://doi.org/10.1182/blood-2016-01-694349

Published: 2016

Includes: Supplemental data

Journal Articles

t(12;21)/ ETV6 - RUNX1 Confers a Specific Pattern of In Vivo Sensitivity to Treatments in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Results of the Randomized Trials 58881 and 58951 of the EORTC Children Leukemia Group

Blood (2015) 126 (23): 793.

https://doi.org/10.1182/blood.V126.23.793.793

Published: 2015

Journal Articles

Hematopoietic Stem Cell Transplantation from HLA Identical Sibling Forsickle Cell Disease an International Survey on Behalf of Eurocord-Monacord, EBMT Paediatric Disease Working Party and CIBMTR

Blood (2015) 126 (23): 541.

https://doi.org/10.1182/blood.V126.23.541.541

Published: 2015

Journal Articles

Response: Confounding by indication is unlikely to explain the higher inhibitor incidence in boys treated with a recombinant FVIII product

Thierry Calvez, Hervé Chambost, Patrick Lutz, Chantal Rothschild, Jenny Goudemand

Blood (2015) 125 (24): 3817–3819.

https://doi.org/10.1182/blood-2015-02-622167

Published: 2015

Includes: Supplemental data

Journal Articles

Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study

Frédéric Millot, Joelle Guilhot, André Baruchel, Arnaud Petit, Yves Bertrand, Françoise Mazingue, Patrick Lutz, Cecile Vérité, Christian Berthou, Claire Galambrun, Nicolas Sirvent, Karima Yakouben, Claudine Schmitt, Virginie Gandemer, Yves Reguerre, Gérard Couillault, Françoise Mechinaud, Jean-Michel Cayuela

Blood (2014) 124 (15): 2408–2410.

https://doi.org/10.1182/blood-2014-05-578567

Published: 2014

Includes: Supplemental data

Journal Articles

Imatinib Has a Negative Impact On Growth In Children With Previously Untreated Chronic Myeloid Leukaemia (CML) In Early Chronic Phase (CP): Results Of The French National Study

Frédéric Millot, Joelle Guilhot, Ph.D., Andre Baruchel, MD, PhD, Arnaud Petit, MD, Thierry Leblanc, MD, Yves Bertrand, Françoise Mazingue, Patrick Lutz, Cécile Vérité, Christian Berthou, Claire Galambrun, Nicolas Sirvent, Karima Yacouben, Pascal Chastagner, Virginie Gandemer, MD, PhD, Yves Reguerre, Gérard Couillaud, Jean-Michel Cayuela

Blood (2013) 122 (21): 4001.

https://doi.org/10.1182/blood.V122.21.4001.4001

Published: 2013

Journal Articles

Molecular Responses At 3 Months Are Associated With a Better Subsequent Molecular response and Outcome In Children and Adolescents With CML In Chronic Phase: Results Of a Retrospective Analysis From The French Glivec Phase 4 Study

Frédéric Millot, Joelle Guilhot, PhD, André Baruchel, MD, Arnaud Petit, MD, Thierry Leblanc, MD, Yves Bertrand, Françoise Mazingue, Patrick Lutz, Cécile Vérité, MD, Christian Berthou, MD, Claire Galambrun, MD, Nicolas Sirvent, Karima Yacouben, Pascal Chastagner, Virginie Gandemer, MD, PhD, Yves Reguerre, MD, Gérard Couillaud, MD, Jean-Michel Cayuela

Blood (2013) 122 (21): 2730.

https://doi.org/10.1182/blood.V122.21.2730.2730

Published: 2013

Journal Articles

Outcomes After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) In 163 Pediatric Patients (<18 years old): A Retrospective Study On Behalf Of The SFGM-TC

Blood (2013) 122 (21): 3283.

https://doi.org/10.1182/blood.V122.21.3283.3283

Published: 2013

Journal Articles

Hematopoietic Stem Cell Transplantation In Relapsed ALK + Anaplastic Large Cell Lymphoma Of Children and adolescent : A Study On Behalf Of The Sfce and SFGM-TC

Marion Strullu, Caroline Thomas, M.D., Nicole Raus, Catherine Paillard, Yves Bertrand, MD, Charlotte Jubert, MD, Regis Peffaut De La Tour, Patrick Lutz, Jean-Hugues Dalle, PhD, MD, Laurence Lamant, MD, PhD, Gerard Michel, Laurence Brugieres, MD

Blood (2013) 122 (21): 2120.

https://doi.org/10.1182/blood.V122.21.2120.2120

Published: 2013

Journal Articles

Sickle Cell Anemia and HSCT: Relation Between ATG, Chimerism, Gvhd and Outcome In Myeloablative Genoidentical Transplants For The SFGM-TC

Francoise Bernaudin, MD, Dominique Bories, MD, PHD, Jean-Hugues Dalle, MD, PHD, Marie Robin, MD, PhD, Regis Peffault de Latour, Benedicte Neven, Yves Bertrand, MD, Corinne Pondarre, MD, PHD, Jean-Pierre Vannier, Karima Yakouben, Mathieu Kuentz, Catherine Cordonnier, Nathalie Dhedin, MD, Isabelle Thuret, Patrick Lutz, Eliane Gluckman, MD, Gérard Socié, MD, PhD

Blood (2013) 122 (21): 971.

https://doi.org/10.1182/blood.V122.21.971.971

Published: 2013

Journal Articles

Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results

Blood (2013) 121 (13): 2415–2423.

https://doi.org/10.1182/blood-2012-06-437681

Published: 2013

Includes: Supplemental data

Journal Articles

Low CNS Relapse Incidence without Radiotherapy and Improvement of Outcome: Results of Subsequent EORTC-CLG 58881 and 58951 Trials in Pediatric T-Cell Acute Lymphoblastic Leukemia (ALL)

Blood (2012) 120 (21): 133.

https://doi.org/10.1182/blood.V120.21.133.133

Published: 2012

Journal Articles

Prolonged E. Coli Asparaginase Therapy Does Not Improve Significantly the Outcome for Children with Low and Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC-CLG Randomized Phase III Trial 58951

Blood (2012) 120 (21): 134.

https://doi.org/10.1182/blood.V120.21.134.134

Published: 2012

Journal Articles

MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival

Nadine T. Nehme, Jana Pachlopnik Schmid, Franck Debeurme, Isabelle André-Schmutz, Annick Lim, Patrick Nitschke, Frédéric Rieux-Laucat, Patrick Lutz, Capucine Picard, Nizar Mahlaoui, Alain Fischer, Geneviève de Saint Basile

Blood (2012) 119 (15): 3458–3468.

https://doi.org/10.1182/blood-2011-09-378364

Published: 2012

Includes: Supplemental data

Journal Articles

The Prognosis of Children Acute Lymphoblastic Leukemia (ALL) with Minimal Residual Disease (MRD) ≥10-2 After Induction (TP1) Depends on the Prephase Response and on the Level of the MRD After Consolidation (TP2): Results of the 58951EORTC Trial

Yves Bertrand, Stefan Suciu, Nathalie Grardel, Marleen Bakkus, PhD, Francoise Mazingue, MD, Karima Yacouben, Anne Uyttebroeck, Patrick Lutz, Dominique Plantaz, Sandrine Girard, Nicole Dastugue, Yves Benoit, MD, Hélène Cavé

Blood (2011) 118 (21): 2571.

https://doi.org/10.1182/blood.V118.21.2571.2571

Published: 2011

NARROW

Risk Factors and Outcomes According to Age at Transplant with an HLA Identical Sibling for Sickle Cell Disease

Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation

Prophylactic CNS Therapy (with or without Radiation Therapy) in Medium-High Risk Acute Lymphoblastic Leukemia (ALL) Children: Long-Term Outcome Evaluation of the Randomized BFM-Oriented Trial 58832 (period 1983-1989) of the EORTC Children Leukemia Group

Metabolic Syndrome in Long-Term Survivors of Childhood Acute Leukemia Treated without Hematopoietic Stem Cell Transplantation: An L.E.Α. Study

Late Effects in Survivors of Infantile Acute Leukemia Are Less Severe Than Expected: A Study of the L.E.a Program

Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome

t(12;21)/ ETV6 - RUNX1 Confers a Specific Pattern of In Vivo Sensitivity to Treatments in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Results of the Randomized Trials 58881 and 58951 of the EORTC Children Leukemia Group

Hematopoietic Stem Cell Transplantation from HLA Identical Sibling Forsickle Cell Disease an International Survey on Behalf of Eurocord-Monacord, EBMT Paediatric Disease Working Party and CIBMTR

Response: Confounding by indication is unlikely to explain the higher inhibitor incidence in boys treated with a recombinant FVIII product

Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study

Imatinib Has a Negative Impact On Growth In Children With Previously Untreated Chronic Myeloid Leukaemia (CML) In Early Chronic Phase (CP): Results Of The French National Study

Molecular Responses At 3 Months Are Associated With a Better Subsequent Molecular response and Outcome In Children and Adolescents With CML In Chronic Phase: Results Of a Retrospective Analysis From The French Glivec Phase 4 Study

Outcomes After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) In 163 Pediatric Patients (<18 years old): A Retrospective Study On Behalf Of The SFGM-TC

Hematopoietic Stem Cell Transplantation In Relapsed ALK + Anaplastic Large Cell Lymphoma Of Children and adolescent : A Study On Behalf Of The Sfce and SFGM-TC

Sickle Cell Anemia and HSCT: Relation Between ATG, Chimerism, Gvhd and Outcome In Myeloablative Genoidentical Transplants For The SFGM-TC

Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results

Low CNS Relapse Incidence without Radiotherapy and Improvement of Outcome: Results of Subsequent EORTC-CLG 58881 and 58951 Trials in Pediatric T-Cell Acute Lymphoblastic Leukemia (ALL)

Prolonged E. Coli Asparaginase Therapy Does Not Improve Significantly the Outcome for Children with Low and Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC-CLG Randomized Phase III Trial 58951

MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival

The Prognosis of Children Acute Lymphoblastic Leukemia (ALL) with Minimal Residual Disease (MRD) ≥10-2 After Induction (TP1) Depends on the Prephase Response and on the Level of the MRD After Consolidation (TP2): Results of the 58951EORTC Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only